oral+semaglutide+approval For patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is approved for weight management as a once-weekly subcutaneous injection. In a previous trial, oral semaglutide at a dose of 50 mg Drug Watch: The oral version

These drugs bind to hypothalamic estrogen receptors in the brain, which tricks the body into thinking that its not getting enough estrogen

The category is expanding quickly, but the approved options are still limited and the science behind swallowing a peptide is genuinely interesting

While both drugs target similar pathways, they should not be mixed unless specifically directed by a healthcare professional

GLP-1 medications act like a natural gut hormone, explains Dr

For mild to high-risk procedures or if the last GLP-1 dose was within days, consider rapid-sequence induction, use of cricoid pressure where appropriate, or endotracheal intubation rather than laryngeal mask airway

While every campaign is unique, you can typically expect to see some traction within 30 to 60 days